Innventure Reports Third Quarter 2025 Results GlobeNewswire November 13, 2025 Accelsius recently secured strategic investment from Johnson Controls and introduced its NeuCool(R) MR250 system; pipeline of opportunities now exceeds $1 billion AeroFlexx delivered 5th consecutive quarter of revenue generation with growing customer pipeline in U.S. and Europe Refinity on track to demonstrate pilot scale and […]
NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations GlobeNewswire November 13, 2025 Four new patent applications filed that aim to expand the Curadigm Nanoprimer platform intellectual property portfolio and support an initial proprietary internal pipeline of Nanoprimer products in addition to external collaborations New in vivo pre-clinical
(NASDAQ:EZPW), Record Q4 and Full Year Revenue & PLOStrong Growth in Diluted EPS & Adjusted EBITDA AUSTIN, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) — EZCORP, Inc. (NASDAQ: EZPW), a leading provider of pawn transactions in the United States and Latin America, today announced results for its fourth quarter and full year ended September 30, 2025.
EZCORP Reports Fourth Quarter and Full Year Fiscal 2025 Results GlobeNewswire November 13, 2025 Record Q4 and Full Year Revenue & PLOStrong Growth in Diluted EPS & Adjusted EBITDA AUSTIN, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) — EZCORP, Inc. (NASDAQ: EZPW), a leading provider of pawn transactions in the United States and Latin America, today
(Brussels:NYXH),(NasdaqGM:NYXH), REGULATED INFORMATION Nyxoah Reports Third Quarter 2025 Financial and Operating Results US launch off to a strong start. First commercial Genio implants completed with widespread payer coverage drives initial revenue. Mont-Saint-Guibert, Belgium – November 13, 2025, 10:10pm CET / 4:10 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical
Blue Moon Metals Inc.(“Blue Moon” or the “Company”) (TSXV: MOON) (OTCQX: BMOOF), is pleased to report the voting results from the Company's Annual General and Special Meeting of Shareholders (the “Meeting”), which was held earlier today in Toronto, Canada. A total of 65,105,641 common shares were present or represented at the Meeting, representing approximately 80.53%
Earvin “Magic” Johnson to Serve as Grand Marshal; Theme Celebrates “The Magic in Teamwork” as Viewers Experience the Grandeur of one of America's Most Beloved Traditions, January 1, Live from Pasadena, California Great American Mediatoday proudly announced it will serve as the national linear, digital, and streaming home to the 137th Rose Parade® presented by
Nyxoah Reports Third Quarter 2025 Financial and Operating Results GlobeNewswire November 13, 2025 REGULATED INFORMATION Nyxoah Reports Third Quarter 2025 Financial and Operating Results US launch off to a strong start. First commercial Genio implants completed with widespread payer coverage drives initial revenue. Mont-Saint-Guibert, Belgium – November 13, 2025, 10:10pm CET / 4:10 pm ET
Conference call to discuss financial and operational results scheduled for Friday, November 14 at 8:30 a.m. U.S. Eastern Time VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, today announces financial results and a business update for the third quarter ended September 30, 2025. Volition management will host a conference call tomorrow, November 14
Smartkem (Nasdaq: SMTK), which is seeking to change the world of electronics with a new class of transistor technology, today provides a business update and reports its financial results for the three and nine months ended September 30, 2025. https://mma.prnewswire.com/media/2822344/Logo___Smartkem.jpg Third Quarter 2025 Highlights: — Signed a non-binding Letter of Intent with Jericho Energy Ventures